We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Recent reports have indicated that the National Medical Products Administration has addressed the potential carcinogenicity associated with CAR-T cell immunotherapy.
Many previous studies have shown that statins are able to have an impact on cancer cells but the results have yet to be seen in human trials. Keele University has now conducted research that could point towards why they have proved ineffective so far.